{"id":1607,"date":"2016-05-01T09:49:45","date_gmt":"2016-05-01T09:49:45","guid":{"rendered":"https:\/\/lynxee.consulting\/en\/?p=1607"},"modified":"2016-05-18T09:50:03","modified_gmt":"2016-05-18T09:50:03","slug":"france-new-form-for-the-declaration-of-officially-recognised-trials","status":"publish","type":"post","link":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/","title":{"rendered":"FRANCE: new form for the declaration of Officially Recognised Trials"},"content":{"rendered":"

In France, this new form to be sent to ANSES replaces Coleor portal that served to date for the declaration of Officially Recognised Trials.<\/p>\n

This form meets the requirements of Article 9 of the Order of 26 April 2007. It should be sent to ANSES when setting up trials before the end of the assessments and 20 days at the latest after the first application of the test products, and when closing the trials 20 days at the latest after the end of the assessments or crop destruct.<\/p>\n

It should be sent both for trials that are conducted following an application for trial permit and for trials carried out under an \u201cexemption from application for trial permit\u201d (see our previous article).<\/p>\n

 <\/p>\n

For download:<\/strong><\/p>\n

Declaration of Officially Recognised Trials:<\/p>\n

Form (in French)<\/a><\/p>\n

Order of 26 April 2007 (in French)<\/a><\/p>\n

Declaration of trials carried out under an \u201cexemption from application for trial permit\u201d:<\/p>\n

Form (in French)<\/a><\/p>\n

Order of 9 February 2016 (in French)<\/a><\/p>\n

 <\/p>\n

Our previous article:<\/strong><\/p>\n

FRANCE: the order for the \u201cExemption from application for trial permit\u201d is published!<\/a><\/p>\n

 <\/p>\n

Lynxee consulting\u2019s team is at your disposal to answer your questions.<\/p>\n

Contact us! https:\/\/lynxee.consulting\/en\/contact\/<\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

In France, this new form to be sent to ANSES replaces Coleor portal that served to date for the declaration of Officially Recognised Trials. This form [\u2026]<\/span><\/p>\n","protected":false},"author":4,"featured_media":1606,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[178],"class_list":["post-1607","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulation","tag-efficacy-trials"],"yoast_head":"\nFRANCE: new form for the declaration of Officially Recognised Trials - Lynxee consulting<\/title>\n<meta name=\"description\" content=\"In France, this new form to be sent to ANSES replaces Coleor portal that served to date for the declaration of Officially Recognised Trials. This form\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FRANCE: new form for the declaration of Officially Recognised Trials - Lynxee consulting\" \/>\n<meta property=\"og:description\" content=\"In France, this new form to be sent to ANSES replaces Coleor portal that served to date for the declaration of Officially Recognised Trials. This form\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Lynxee consulting\" \/>\n<meta property=\"article:published_time\" content=\"2016-05-01T09:49:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-05-18T09:50:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2016\/05\/wheat-175960_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1078\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Vianay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Vianay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/\"},\"author\":{\"name\":\"\u00c9milie Vianay\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\"},\"headline\":\"FRANCE: new form for the declaration of Officially Recognised Trials\",\"datePublished\":\"2016-05-01T09:49:45+00:00\",\"dateModified\":\"2016-05-18T09:50:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/\"},\"wordCount\":201,\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2016\\\/05\\\/wheat-175960_1920.jpg\",\"keywords\":[\"efficacy trials\"],\"articleSection\":[\"Regulation\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/\",\"name\":\"FRANCE: new form for the declaration of Officially Recognised Trials - Lynxee consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2016\\\/05\\\/wheat-175960_1920.jpg\",\"datePublished\":\"2016-05-01T09:49:45+00:00\",\"dateModified\":\"2016-05-18T09:50:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\"},\"description\":\"In France, this new form to be sent to ANSES replaces Coleor portal that served to date for the declaration of Officially Recognised Trials. This form\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2016\\\/05\\\/wheat-175960_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2016\\\/05\\\/wheat-175960_1920.jpg\",\"width\":1920,\"height\":1078},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/france-new-form-for-the-declaration-of-officially-recognised-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FRANCE: new form for the declaration of Officially Recognised Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/\",\"name\":\"Lynxee consulting\",\"description\":\"Innovative support for regulatory issues\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lynxee.consulting\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\",\"name\":\"\u00c9milie Vianay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"caption\":\"\u00c9milie Vianay\"},\"sameAs\":[\"https:\\\/\\\/lynxee.consulting\"],\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/author\\\/emilie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FRANCE: new form for the declaration of Officially Recognised Trials - Lynxee consulting","description":"In France, this new form to be sent to ANSES replaces Coleor portal that served to date for the declaration of Officially Recognised Trials. This form","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/","og_locale":"en_US","og_type":"article","og_title":"FRANCE: new form for the declaration of Officially Recognised Trials - Lynxee consulting","og_description":"In France, this new form to be sent to ANSES replaces Coleor portal that served to date for the declaration of Officially Recognised Trials. This form","og_url":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/","og_site_name":"Lynxee consulting","article_published_time":"2016-05-01T09:49:45+00:00","article_modified_time":"2016-05-18T09:50:03+00:00","og_image":[{"width":1920,"height":1078,"url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2016\/05\/wheat-175960_1920.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Vianay","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Vianay","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/#article","isPartOf":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/"},"author":{"name":"\u00c9milie Vianay","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d"},"headline":"FRANCE: new form for the declaration of Officially Recognised Trials","datePublished":"2016-05-01T09:49:45+00:00","dateModified":"2016-05-18T09:50:03+00:00","mainEntityOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/"},"wordCount":201,"image":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2016\/05\/wheat-175960_1920.jpg","keywords":["efficacy trials"],"articleSection":["Regulation"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/","url":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/","name":"FRANCE: new form for the declaration of Officially Recognised Trials - Lynxee consulting","isPartOf":{"@id":"https:\/\/lynxee.consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/#primaryimage"},"image":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2016\/05\/wheat-175960_1920.jpg","datePublished":"2016-05-01T09:49:45+00:00","dateModified":"2016-05-18T09:50:03+00:00","author":{"@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d"},"description":"In France, this new form to be sent to ANSES replaces Coleor portal that served to date for the declaration of Officially Recognised Trials. This form","breadcrumb":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/#primaryimage","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2016\/05\/wheat-175960_1920.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2016\/05\/wheat-175960_1920.jpg","width":1920,"height":1078},{"@type":"BreadcrumbList","@id":"https:\/\/lynxee.consulting\/en\/france-new-form-for-the-declaration-of-officially-recognised-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lynxee.consulting\/en\/"},{"@type":"ListItem","position":2,"name":"FRANCE: new form for the declaration of Officially Recognised Trials"}]},{"@type":"WebSite","@id":"https:\/\/lynxee.consulting\/#website","url":"https:\/\/lynxee.consulting\/","name":"Lynxee consulting","description":"Innovative support for regulatory issues","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lynxee.consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d","name":"\u00c9milie Vianay","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","caption":"\u00c9milie Vianay"},"sameAs":["https:\/\/lynxee.consulting"],"url":"https:\/\/lynxee.consulting\/en\/author\/emilie\/"}]}},"_links":{"self":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/1607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/comments?post=1607"}],"version-history":[{"count":2,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/1607\/revisions"}],"predecessor-version":[{"id":1609,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/1607\/revisions\/1609"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media\/1606"}],"wp:attachment":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media?parent=1607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/categories?post=1607"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/tags?post=1607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}